Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans

被引:29
作者
Paderu, P [1 ]
Park, S [1 ]
Perlin, DS [1 ]
机构
[1] Int Ctr Publ Hlth, Publ Hlth Res Inst, Newark, NJ 07103 USA
关键词
D O I
10.1128/AAC.48.10.3845-3849.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The uptake of the echinocandin drug caspofungin acetate in Candida albicans was evaluated at drug levels at or near the MIC for the organism. Maximal uptake was achieved in 10 min and was energy independent. A saturable transport system, consistent with a facilitated-diffusion carrier, was observed with the unlabeled drug competing with the labeled drug for uptake and efflux. More than 90% of the transported drug was observed in a single kinetic compartment that was available for efflux, indicating that the drug was free in the cytoplasm following uptake. Efflux was also energy independent but was sensitive to the presence of a fully loaded carrier on both faces of the bilayer. Overall, the data presented are consistent with the presence of a high-affinity facilitated-diffusion transporter that mediates caspofungin uptake and could be a potential source of transport-related reduced susceptibility.
引用
收藏
页码:3845 / 3849
页数:5
相关论文
共 20 条
[1]   Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae [J].
Agarwal, AK ;
Rogers, PD ;
Baerson, SR ;
Jacob, MR ;
Barker, KS ;
Cleary, JD ;
Walker, LA ;
Nagle, DG ;
Clark, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34998-35015
[2]   Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans [J].
Baev, D ;
Li, XWS ;
Dong, J ;
Keng, P ;
Edgerton, M .
INFECTION AND IMMUNITY, 2002, 70 (09) :4777-4784
[3]   Echinocandin antifungal drugs [J].
Denning, DW .
LANCET, 2003, 362 (9390) :1142-1151
[4]   A SACCHAROMYCES-CEREVISIAE MUTANT WITH ECHINOCANDIN-RESISTANT 1,3-BETA-D-GLUCAN SYNTHASE [J].
DOUGLAS, CM ;
MARRINAN, JA ;
LI, W ;
KURTZ, MB .
JOURNAL OF BACTERIOLOGY, 1994, 176 (18) :5686-5696
[5]  
Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66
[6]  
DOUGLAS DJA, 1994, COMMUNITY EC DEV CAN, V1, P1
[7]   Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein [J].
Kelly, R ;
Register, E ;
Hsu, MJ ;
Kurtz, M ;
Nielsen, J .
JOURNAL OF BACTERIOLOGY, 1996, 178 (15) :4381-4391
[8]   Aspergillus nidulans is frequently resistant to amphotericin B [J].
Kontoyiannis, DP ;
Lewis, RE ;
May, GS ;
Osherov, N ;
Rinaldi, MG .
MYCOSES, 2002, 45 (9-10) :406-407
[9]   Characterization of echinocardin-resistant mutants of Candida albicans: Genetic, biochemical, and virulence studies [J].
Kurtz, MB ;
Abruzzo, G ;
Bartizal, K ;
Marrinan, JA ;
Li, W ;
Milligan, J ;
Nollstadt, K ;
Douglas, CM .
INFECTION AND IMMUNITY, 1996, 64 (08) :3244-3251
[10]   In vitro activity of 1,3-beta-D-glucan synthase requires the GTP-binding protein Rho1 [J].
Mazur, P ;
Baginsky, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14604-14609